Humana Inc (NYSE:HUM)
$ 335.59 0.91 (0.27%) Market Cap: 40.44 Bil Enterprise Value: 47.74 Bil PE Ratio: 20.90 PB Ratio: 2.51 GF Score: 83/100

Humana Inc at Goldman Sachs Healthcare CEOs Unscripted Conference (Virtual) Transcript

Jan 05, 2021 / 08:20PM GMT
Release Date Price: $413.18 (+0.24%)
Robert Patrick Jones
Goldman Sachs Group, Inc., Research Division - VP

Good afternoon, everyone, and welcome to the Humana session. I'm Bob Jones here at Goldman Sachs. I cover healthcare services and managed care. I'm very excited to have President and CEO, Bruce Broussard from Humana with us as well as Amy Smith, VP of Investor Relations. So a Happy New Year, and welcome to you both. We're going to obviously ask a series of questions here.

Questions & Answers

Robert Patrick Jones;Bruce Dale
Goldman Sachs Group, Inc., Research Division - VP

A lot of things are very topical. But I thought, Bruce, maybe just given how top of mind it is right now for everyone? Wanted to just start with the vaccine and the rollout specifically. I know it's very early days, but there's some debate on how the rollout has progressed. Just curious for Humana's perspective on how they've seen the vaccine rollout began. And then more specifically, are there specific things you managed doing to encourage members or educate members around getting back to date?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot